Silo Pharma Inc (SILO) — Cash Flow-to-Debt Ratio
Silo Pharma Inc (SILO) has a Cash Flow-to-Debt Ratio of -0.73x as of June 2026, meaning its operating cash flow of $-781.86K could theoretically repay -1% of its total liabilities ($1.07 Million) in one year. See how financially flexible is Silo Pharma Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Silo Pharma Inc Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Silo Pharma Inc across 15 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Silo Pharma Inc.
Annual Cash Flow-to-Debt Ratio for Silo Pharma Inc (2011–2025)
Year-by-year debt coverage analysis for Silo Pharma Inc. Check earnings quality score of Silo Pharma Inc to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.59x | $-4.66 Million | $1.30 Million | ▼ -122.4% |
| 2024 | -1.61x | $-3.83 Million | $2.38 Million | ▲ +21.5% |
| 2023 | -2.05x | $-3.22 Million | $1.57 Million | ▲ +23.5% |
| 2022 | -2.69x | $-3.50 Million | $1.30 Million | ▼ -68.4% |
| 2021 | -1.60x | $-2.28 Million | $1.43 Million | ▲ +79.9% |
| 2020 | -7.93x | $-1.16 Million | $145.97K | ▼ -415.6% |
| 2019 | -1.54x | $-794.32K | $516.74K | ▼ -352.6% |
| 2018 | 0.61x | $272.64K | $447.98K | ▲ +193.7% |
| 2017 | -0.65x | $-284.62K | $438.34K | ▼ -104.9% |
| 2016 | -0.32x | $-143.56K | $453.10K | ▲ +84.7% |
| 2015 | -2.07x | $-1.02 Million | $490.76K | ▲ +21.5% |
| 2014 | -2.64x | $-1.06 Million | $402.56K | ▼ -508.8% |
| 2013 | -0.43x | $-181.61K | $418.72K | ▲ +16.2% |
| 2012 | -0.52x | $-21.47K | $41.47K | ▲ +96.1% |
| 2011 | -13.23x | $-46.30K | $3.50K | — |